论文信息 - Addressing the Challenges of Eosinophilia and Mastocytosis.

Addressing the Challenges of Eosinophilia and Mastocytosis.

From the Division of Hematopathology, Mayo Clinic, Phoenix, AZ; Division of Hematopathology, Mayo Clinic, Rochester, MN; Department of Pathology, University of Utah School of Medicine, Salt Lake City; Institute of Pathology, University of Munich (LMU), Munich, Germany; Department of Pathology, Texas Tech University Health Sciences Center, P. L. Foster School of Medicine, El Paso; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, Tübingen University Hospital, Tübingen, Germany; and Department of Hematopathology, MD Anderson Cancer Center, Houston, TX.

[1] G. Wertheim,et al. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders. , 2020, American journal of clinical pathology.

[2] L. Rimsza,et al. Reactive Eosinophil Proliferations in Tissue and the Lymphocytic Variant of Hypereosinophilic Syndrome. , 2020, American journal of clinical pathology.

[3] L. Rimsza,et al. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. , 2020, American Journal of Clinical Pathology.